Published in J Infect Dis on September 08, 2000
Evolutionary pathway to increased virulence and epidemic group A Streptococcus disease derived from 3,615 genome sequences. Proc Natl Acad Sci U S A (2014) 2.63
A molecular trigger for intercontinental epidemics of group A Streptococcus. J Clin Invest (2015) 1.29
The Rgg regulator of Streptococcus pyogenes influences utilization of nonglucose carbohydrates, prophage induction, and expression of the NAD-glycohydrolase virulence operon. J Bacteriol (2006) 1.21
A novel endogenous inhibitor of the secreted streptococcal NAD-glycohydrolase. PLoS Pathog (2005) 1.20
Role of NADase in virulence in experimental invasive group A streptococcal infection. Infect Immun (2005) 1.20
Identification and characterization of bicistronic speB and prsA gene expression in the group A Streptococcus. J Bacteriol (2006) 1.07
Streptococcus pyogenes cytolysin-mediated translocation does not require pore formation by streptolysin O. EMBO Rep (2010) 1.06
Variation in Streptococcus pyogenes NAD+ glycohydrolase is associated with tissue tropism. J Bacteriol (2010) 1.03
Characterization of Streptococcus pyogenes beta-NAD+ glycohydrolase: re-evaluation of enzymatic properties associated with pathogenesis. J Biol Chem (2009) 0.99
Extracellular enzymes with immunomodulating activities: variations on a theme in Streptococcus pyogenes. Infect Immun (2003) 0.99
Growth phase-dependent effect of clindamycin on production of exoproteins by Streptococcus pyogenes. Antimicrob Agents Chemother (2006) 0.92
Structural basis of Streptococcus pyogenes immunity to its NAD+ glycohydrolase toxin. Structure (2011) 0.88
Analysis of polymorphic residues reveals distinct enzymatic and cytotoxic activities of the Streptococcus pyogenes NAD+ glycohydrolase. J Biol Chem (2013) 0.87
NAD-glycohydrolase production and speA and speC distribution in Group A streptococcus (GAS) isolates do not correlate with severe GAS diseases in the Australian population. J Clin Microbiol (2002) 0.86
The tuberculosis necrotizing toxin kills macrophages by hydrolyzing NAD. Nat Struct Mol Biol (2015) 0.84
NADase as a target molecule of in vivo suppression of the toxicity in the invasive M-1 group A Streptococcal isolates. BMC Microbiol (2010) 0.84
Partial loss of CovS function in Streptococcus pyogenes causes severe invasive disease. BMC Res Notes (2013) 0.80
The Streptococcus pyogenes NAD(+) glycohydrolase modulates epithelial cell PARylation and HMGB1 release. Cell Microbiol (2015) 0.79
NAD+-Glycohydrolase Promotes Intracellular Survival of Group A Streptococcus. PLoS Pathog (2016) 0.79
Mapping the protein-protein interface between a toxin and its cognate antitoxin from the bacterial pathogen Streptococcus pyogenes. Biochemistry (2011) 0.78
Identification of NAD+ synthetase from Streptococcus sobrinus as a B-cell-stimulatory protein. J Bacteriol (2004) 0.77
Cardiac myocyte dysfunction induced by streptolysin O is membrane pore and calcium dependent. Shock (2015) 0.75
High-resolution crystal structure of Streptococcus pyogenes β-NAD⁺ glycohydrolase in complex with its endogenous inhibitor IFS reveals a highly water-rich interface. J Synchrotron Radiat (2013) 0.75
Global Analysis and Comparison of the Transcriptomes and Proteomes of Group A Streptococcus Biofilms. mSystems (2016) 0.75
Virulence studies on chromosomal alpha-toxin and theta-toxin mutants constructed by allelic exchange provide genetic evidence for the essential role of alpha-toxin in Clostridium perfringens-mediated gas gangrene. Mol Microbiol (1995) 2.79
Clostridium sordellii infection: epidemiology, clinical findings, and current perspectives on diagnosis and treatment. Clin Infect Dis (2006) 2.52
Identification and molecular analysis of a locus that regulates extracellular toxin production in Clostridium perfringens. Mol Microbiol (1994) 2.37
Evaluation of therapy with hyperbaric oxygen for experimental infection with Clostridium perfringens. Clin Infect Dis (1993) 2.07
Staging of the baboon response to group A streptococci administered intramuscularly: a descriptive study of the clinical symptoms and clinical chemical response patterns. Clin Infect Dis (1999) 1.71
Penicillin-binding protein expression at different growth stages determines penicillin efficacy in vitro and in vivo: an explanation for the inoculum effect. J Infect Dis (1993) 1.54
Clostridial gas gangrene: evidence that alpha and theta toxins differentially modulate the immune response and induce acute tissue necrosis. J Infect Dis (1997) 1.52
Defective low-density cells of dendritic morphology from the blood of patients with common variable hypogammaglobulinaemia: low immunoglobulin production on stimulation of normal B cells. Clin Exp Immunol (1985) 1.42
Antibiotic effects on bacterial viability, toxin production, and host response. Clin Infect Dis (1995) 1.32
Maternal cotinine level during pregnancy and birthweight for gestational age. Int J Epidemiol (1998) 1.29
Determination of cotinine in biological fluids of non-smokers by packed column gas-liquid chromatography. J Pharm Pharmacol (1986) 1.22
Alpha toxin from Clostridium perfringens induces proinflammatory changes in endothelial cells. J Clin Invest (1997) 1.16
Group A streptococcal bacteremia: the role of tumor necrosis factor in shock and organ failure. J Infect Dis (1996) 1.10
Construction and virulence testing of a collagenase mutant of Clostridium perfringens. Microb Pathog (2000) 1.06
Thyroglobulin-treated blood dendritic cells induce IgG anti-thyroglobulin antibody in vitro in Hashimoto's thyroiditis. Clin Immunol Immunopathol (1986) 0.95
Effects of Clostridium perfringens recombinant and crude phospholipase C and theta-toxin on rabbit hemodynamic parameters. J Infect Dis (1995) 0.91
Invasive group A streptococcal infection: New concepts in antibiotic treatment. Int J Antimicrob Agents (1994) 0.90
Role of theta toxin, a sulfhydryl-activated cytolysin, in the pathogenesis of clostridial gas gangrene. Clin Infect Dis (1993) 0.88
Comparison of functional magnetic resonance imaging for language localization and intracarotid speech amytal testing in presurgical evaluation for intractable epilepsy. Preliminary results. Stereotact Funct Neurosurg (1997) 0.87
The effect of cortisol suppression on interleukin-6 and white blood cell responses to surgery. Acta Anaesthesiol Scand (1997) 0.85
Efficacy of varying concentrations of hyaluronidase in peribulbar anaesthesia. Br J Anaesth (2001) 0.83
Pathogenesis of Clostridium perfringens infection: mechanisms and mediators of shock. Clin Infect Dis (1997) 0.82
Analysis of circulating phagocyte activity measured by whole blood luminescence: correlations with clinical status. J Infect Dis (1994) 0.79
Osteocalcin and the hormonal, inflammatory and metabolic response to major orthopaedic surgery. Anaesthesia (2002) 0.79
Etomidate and the osteocalcin response to gynaecological surgery. Br J Anaesth (1999) 0.78
LFA-1-dependent OKT3-driven T cell clusters in common variable immunodeficiency. Clin Exp Immunol (1992) 0.77
Epidural analgesia and arterial reconstructive surgery to the leg: effects on fibrinolysis and platelet degranulation. Br J Anaesth (2001) 0.77
Innate immune recognition of, and response to, Clostridium sordellii. Anaerobe (2009) 0.77
Streptolysin O modulates cytokine synthesis in human peripheral blood mononuclear cells. Adv Exp Med Biol (1997) 0.77
Type-specific opsonophagocytosis of group A Streptococcus by use of a rapid chemiluminescence assay. J Infect Dis (1999) 0.77
A critical role of tumor necrosis factor (TNF) alpha in experimental group A streptococcal (GAS) bacteremia. Adv Exp Med Biol (1997) 0.75
The hormonal and inflammatory responses to pelvic reconstructive surgery following major trauma. Injury (2005) 0.75
Determination of cotinine in physiological fluids by gas chromatography. IARC Sci Publ (1987) 0.75